borderline resectable pancreatic adenocarcinoma

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023

Survival, Quality of Life and Resectability in Locally Advanced

Recruiting
  • Pancreas Cancer
  • +8 more
    • Umeå, Sweden
      Surgical Clinic at Umeå University Hospital
    Nov 23, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +5 more
    • Durvalumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Sep 16, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in

    Completed
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +6 more
    • Houston, Texas
    • +4 more
    Aug 31, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +3 more
    • Hafnium Oxide-containing Nanoparticles NBTXR3
    • Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

    Recruiting
    • Untreated Resectable Pancreatic Adenocarcinoma
    • +2 more
    • Paclitaxel protein bound
    • +3 more
    • Scottsdale, Arizona
      HonorHealth Research Institute
    May 10, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +11 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Mar 22, 2022

    Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma Trial (Stereotactic Ablative Body

    Not yet recruiting
    • Resectable Pancreatic Adenocarcinoma
    • Borderline Resectable Pancreatic Adenocarcinoma
    • Stereotactic Ablative Body Radiotherapy (SABR)
    • (no location specified)
    Jun 16, 2021

    Neoadjuvant Chemotherapy in Borderline Resectable and Locally

    Recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • +3 more
    • Oslo, Norway
      Oslo University Hospital
    Jun 5, 2020